According to Latest Study, the global market for Enoxaparin Sodium APIs and Preparations should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Enoxaparin Sodium APIs and Preparations market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Enoxaparin Sodium APIs and Preparations market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, 20 mg/0.2mL segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Deep Vein Thrombosis has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Enoxaparin Sodium APIs and Preparations include Shandong Haike Chemical Group Co., Ltd, Manus Aktteva Biopharma LLP, Chemi SPA, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Venus Remedies Ltd, JoinHub Pharma, Memphis Vision Care, Shenzhen Techdow Pharmaceutical Co., Ltd. and Hebei Changshan Biochemical Pharmaceutical Co. Ltd., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Enoxaparin Sodium APIs and Preparations. Report Highlights:
(1) Global Enoxaparin Sodium APIs and Preparations market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.
(2) Global Enoxaparin Sodium APIs and Preparations market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Enoxaparin Sodium APIs and Preparations market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Enoxaparin Sodium APIs and Preparations segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Enoxaparin Sodium APIs and Preparations segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Enoxaparin Sodium APIs and Preparations, capacity, production and trends.
(7) Enoxaparin Sodium APIs and Preparations industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
20 mg/0.2mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Market segment by application, can be divided into
Deep Vein Thrombosis
Pulmonary Embolism
Others
Market segment by players, this report covers
Shandong Haike Chemical Group Co., Ltd
Manus Aktteva Biopharma LLP
Chemi SPA
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Venus Remedies Ltd
JoinHub Pharma
Memphis Vision Care
Shenzhen Techdow Pharmaceutical Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Meithal Pharmaceuticals
Gland Pharma
Dongying Tiandong Pharmaceutical Co., Ltd.
1 Market Overview
1.1 Enoxaparin Sodium APIs and Preparations Definition
1.2 Global Enoxaparin Sodium APIs and Preparations Market Size and Forecast
1.2.1 By Revenue, Global Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
1.2.2 By Sales Volume, Global Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
1.2.3 Global Enoxaparin Sodium APIs and Preparations Price Trend, 2019-2030
1.3 China Enoxaparin Sodium APIs and Preparations Market Size and Forecast
1.3.1 By Revenue, China Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
1.3.2 By Sales Volume, China Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
1.3.3 China Enoxaparin Sodium APIs and Preparations Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Enoxaparin Sodium APIs and Preparations Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Enoxaparin Sodium APIs and Preparations Share in Global Market, 2019-2030
1.4.3 Enoxaparin Sodium APIs and Preparations Market Size: China VS Global, 2019-2030
1.5 Enoxaparin Sodium APIs and Preparations Market Dynamics
1.5.1 Enoxaparin Sodium APIs and Preparations Market Drivers
1.5.2 Enoxaparin Sodium APIs and Preparations Market Restraints
1.5.3 Enoxaparin Sodium APIs and Preparations Industry Trends
1.5.4 Enoxaparin Sodium APIs and Preparations Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024
2.2 Global Enoxaparin Sodium APIs and Preparations Sales Volume by Company, 2019-2024
2.3 Global Enoxaparin Sodium APIs and Preparations Price by Company, 2019-2024
2.4 Global Enoxaparin Sodium APIs and Preparations Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Enoxaparin Sodium APIs and Preparations Concentration Ratio
2.6 Global Enoxaparin Sodium APIs and Preparations Mergers & Acquisitions, Expansion Plans
2.7 Global Enoxaparin Sodium APIs and Preparations Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024
3.2 China Enoxaparin Sodium APIs and Preparations Sales Volume by Company, 2019-2024
3.3 China Enoxaparin Sodium APIs and Preparations Enoxaparin Sodium APIs and Preparations Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Enoxaparin Sodium APIs and Preparations Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Enoxaparin Sodium APIs and Preparations Domestic VS Export
3.6 China Market, Enoxaparin Sodium APIs and Preparations Import & Export
3.6.1 China Market, Enoxaparin Sodium APIs and Preparations Import & Export, 2019-2030
3.6.2 China Enoxaparin Sodium APIs and Preparations Import & Export Trends
3.6.3 Main Sources of China Enoxaparin Sodium APIs and Preparations Import
3.6.4 Export Destination of China Enoxaparin Sodium APIs and Preparations
4 Enoxaparin Sodium APIs and Preparations Production by Region
4.1 Global Enoxaparin Sodium APIs and Preparations Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Enoxaparin Sodium APIs and Preparations Manufacturers
4.3 Global Major Manufacturers, Enoxaparin Sodium APIs and Preparations Capacity Expansion and Future Plans
4.4 Global Enoxaparin Sodium APIs and Preparations Capacity by Region
4.5 Global Enoxaparin Sodium APIs and Preparations Production by Region
4.5.1 Global Enoxaparin Sodium APIs and Preparations Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Enoxaparin Sodium APIs and Preparations Production by Region, 2019-2024
4.5.3 Global Enoxaparin Sodium APIs and Preparations Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Enoxaparin Sodium APIs and Preparations Industry Chain
5.2 Enoxaparin Sodium APIs and Preparations Upstream Analysis
5.2.1 Enoxaparin Sodium APIs and Preparations Core Raw Materials
5.2.2 Main Manufacturers of Enoxaparin Sodium APIs and Preparations Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Enoxaparin Sodium APIs and Preparations Production Mode
5.6 Enoxaparin Sodium APIs and Preparations Procurement Model
5.7 Enoxaparin Sodium APIs and Preparations Industry Sales Model and Sales Channels
5.7.1 Enoxaparin Sodium APIs and Preparations Sales Model
5.7.2 Enoxaparin Sodium APIs and Preparations Typical Distributors
6 Sights by Type
6.1 Enoxaparin Sodium APIs and Preparations Classification
6.1.1 20 mg/0.2mL
6.1.2 40 mg/0.4mL
6.1.3 60 mg/0.6mL
6.1.4 80 mg/0.8mL
6.1.5 100 mg/1mL
6.1.6 120 mg/0.8mL
6.1.7 150 mg/1mL
6.1.8 300mg/3mL
6.2 By Type, Global Enoxaparin Sodium APIs and Preparations Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030
6.4 By Type, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030
6.5 By Type, Global Enoxaparin Sodium APIs and Preparations Price, 2019-2030
7 Sights by Application
7.1 Enoxaparin Sodium APIs and Preparations Segment by Application
7.1.1 Deep Vein Thrombosis
7.1.2 Pulmonary Embolism
7.1.3 Others
7.2 By Application, Global Enoxaparin Sodium APIs and Preparations Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030
7.4 By Application, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030
7.5 By Application, Global Enoxaparin Sodium APIs and Preparations Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Enoxaparin Sodium APIs and Preparations Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030
8.3 By Region, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.5 Europe
8.5.1 Europe Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.7 South America
8.7.1 South America Enoxaparin Sodium APIs and Preparations Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Enoxaparin Sodium APIs and Preparations Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Enoxaparin Sodium APIs and Preparations Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030
9.3 By Country, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.4.2 By Company, U.S. Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.5.2 By Company, Europe Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.5.3 By Type, Europe Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.6.2 By Company, China Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.6.3 By Type, China Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.7.2 By Company, Japan Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.7.3 By Type, Japan Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.8.2 By Company, South Korea Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.10.2 By Company, India Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.10.3 By Type, India Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Enoxaparin Sodium APIs and Preparations Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Enoxaparin Sodium APIs and Preparations Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Shandong Haike Chemical Group Co., Ltd
10.1.1 Shandong Haike Chemical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.1.2 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.1.3 Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Shandong Haike Chemical Group Co., Ltd Company Profile and Main Business
10.1.5 Shandong Haike Chemical Group Co., Ltd Recent Developments
10.2 Manus Aktteva Biopharma LLP
10.2.1 Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area and Industry Position
10.2.2 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.2.3 Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Manus Aktteva Biopharma LLP Company Profile and Main Business
10.2.5 Manus Aktteva Biopharma LLP Recent Developments
10.3 Chemi SPA
10.3.1 Chemi SPA Company Information, Head Office, Market Area and Industry Position
10.3.2 Chemi SPA Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.3.3 Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Chemi SPA Company Profile and Main Business
10.3.5 Chemi SPA Recent Developments
10.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
10.4.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.4.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.4.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Profile and Main Business
10.4.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments
10.5 Venus Remedies Ltd
10.5.1 Venus Remedies Ltd Company Information, Head Office, Market Area and Industry Position
10.5.2 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.5.3 Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Venus Remedies Ltd Company Profile and Main Business
10.5.5 Venus Remedies Ltd Recent Developments
10.6 JoinHub Pharma
10.6.1 JoinHub Pharma Company Information, Head Office, Market Area and Industry Position
10.6.2 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.6.3 JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 JoinHub Pharma Company Profile and Main Business
10.6.5 JoinHub Pharma Recent Developments
10.7 Memphis Vision Care
10.7.1 Memphis Vision Care Company Information, Head Office, Market Area and Industry Position
10.7.2 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.7.3 Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Memphis Vision Care Company Profile and Main Business
10.7.5 Memphis Vision Care Recent Developments
10.8 Shenzhen Techdow Pharmaceutical Co., Ltd.
10.8.1 Shenzhen Techdow Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.8.2 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.8.3 Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Shenzhen Techdow Pharmaceutical Co., Ltd. Company Profile and Main Business
10.8.5 Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments
10.9 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
10.9.1 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Information, Head Office, Market Area and Industry Position
10.9.2 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.9.3 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Profile and Main Business
10.9.5 Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments
10.10 Meithal Pharmaceuticals
10.10.1 Meithal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.10.2 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.10.3 Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Meithal Pharmaceuticals Company Profile and Main Business
10.10.5 Meithal Pharmaceuticals Recent Developments
10.11 Gland Pharma
10.11.1 Gland Pharma Company Information, Head Office, Market Area and Industry Position
10.11.2 Gland Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.11.3 Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Gland Pharma Company Profile and Main Business
10.11.5 Gland Pharma Recent Developments
10.12 Dongying Tiandong Pharmaceutical Co., Ltd.
10.12.1 Dongying Tiandong Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position
10.12.2 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
10.12.3 Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Dongying Tiandong Pharmaceutical Co., Ltd. Company Profile and Main Business
10.12.5 Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Enoxaparin Sodium APIs and Preparations Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Enoxaparin Sodium APIs and Preparations Market Restraints
Table 3. Enoxaparin Sodium APIs and Preparations Market Trends
Table 4. Enoxaparin Sodium APIs and Preparations Industry Policy
Table 5. Global Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024, US$ million
Table 6. Global Enoxaparin Sodium APIs and Preparations Revenue Market Share by Company, 2019-2024
Table 7. Global Enoxaparin Sodium APIs and Preparations Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Enoxaparin Sodium APIs and Preparations Sales Volume Market Share by Company, 2019-2024
Table 9. Global Enoxaparin Sodium APIs and Preparations Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Enoxaparin Sodium APIs and Preparations Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Enoxaparin Sodium APIs and Preparations Mergers & Acquisitions, Expansion Plans
Table 12. Global Enoxaparin Sodium APIs and Preparations Manufacturers Product Type
Table 13. China Enoxaparin Sodium APIs and Preparations Revenue by Company, 2019-2024, US$ million
Table 14. China Enoxaparin Sodium APIs and Preparations Revenue Market Share by Company, 2019-2024
Table 15. China Enoxaparin Sodium APIs and Preparations Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Enoxaparin Sodium APIs and Preparations Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Enoxaparin Sodium APIs and Preparations Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Enoxaparin Sodium APIs and Preparations Import & Export Trends
Table 19. Main Sources of China Enoxaparin Sodium APIs and Preparations Import
Table 20. Export Destination of China Enoxaparin Sodium APIs and Preparations
Table 21. Global Headquarters and Manufacturing Base of Enoxaparin Sodium APIs and Preparations Manufacturers
Table 22. Global Major Manufacturers, Enoxaparin Sodium APIs and Preparations Capacity Expansion and Future Plans
Table 23. Global Enoxaparin Sodium APIs and Preparations Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Enoxaparin Sodium APIs and Preparations Production by Region, 2019-2024, (K Units)
Table 25. Global Enoxaparin Sodium APIs and Preparations Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Enoxaparin Sodium APIs and Preparations Upstream (Raw Materials)
Table 27. Global Enoxaparin Sodium APIs and Preparations Typical Customers
Table 28. Enoxaparin Sodium APIs and Preparations Typical Distributors
Table 29. By Type, Global Enoxaparin Sodium APIs and Preparations Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Enoxaparin Sodium APIs and Preparations Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Enoxaparin Sodium APIs and Preparations Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Enoxaparin Sodium APIs and Preparations Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2019-2030
Table 37. By Country, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2019-2030
Table 39. Shandong Haike Chemical Group Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 40. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 41. Shandong Haike Chemical Group Co., Ltd Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Shandong Haike Chemical Group Co., Ltd Company Profile and Main Business
Table 43. Shandong Haike Chemical Group Co., Ltd Recent Developments
Table 44. Manus Aktteva Biopharma LLP Company Information, Head Office, Market Area and Industry Position
Table 45. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 46. Manus Aktteva Biopharma LLP Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Manus Aktteva Biopharma LLP Company Profile and Main Business
Table 48. Manus Aktteva Biopharma LLP Recent Developments
Table 49. Chemi SPA Company Information, Head Office, Market Area and Industry Position
Table 50. Chemi SPA Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 51. Chemi SPA Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Chemi SPA Company Profile and Main Business
Table 53. Chemi SPA Recent Developments
Table 54. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 55. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 56. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Company Profile and Main Business
Table 58. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Recent Developments
Table 59. Venus Remedies Ltd Company Information, Head Office, Market Area and Industry Position
Table 60. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 61. Venus Remedies Ltd Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Venus Remedies Ltd Company Profile and Main Business
Table 63. Venus Remedies Ltd Recent Developments
Table 64. JoinHub Pharma Company Information, Head Office, Market Area and Industry Position
Table 65. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 66. JoinHub Pharma Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. JoinHub Pharma Company Profile and Main Business
Table 68. JoinHub Pharma Recent Developments
Table 69. Memphis Vision Care Company Information, Head Office, Market Area and Industry Position
Table 70. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 71. Memphis Vision Care Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Memphis Vision Care Company Profile and Main Business
Table 73. Memphis Vision Care Recent Developments
Table 74. Shenzhen Techdow Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 75. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 76. Shenzhen Techdow Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Shenzhen Techdow Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 78. Shenzhen Techdow Pharmaceutical Co., Ltd. Recent Developments
Table 79. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Information, Head Office, Market Area and Industry Position
Table 80. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 81. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Company Profile and Main Business
Table 83. Hebei Changshan Biochemical Pharmaceutical Co. Ltd. Recent Developments
Table 84. Meithal Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 85. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 86. Meithal Pharmaceuticals Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Meithal Pharmaceuticals Company Profile and Main Business
Table 88. Meithal Pharmaceuticals Recent Developments
Table 89. Gland Pharma Company Information, Head Office, Market Area and Industry Position
Table 90. Gland Pharma Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 91. Gland Pharma Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Gland Pharma Company Profile and Main Business
Table 93. Gland Pharma Recent Developments
Table 94. Dongying Tiandong Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 95. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Models, Specifications and Application
Table 96. Dongying Tiandong Pharmaceutical Co., Ltd. Enoxaparin Sodium APIs and Preparations Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Dongying Tiandong Pharmaceutical Co., Ltd. Company Profile and Main Business
Table 98. Dongying Tiandong Pharmaceutical Co., Ltd. Recent Developments
List of Figure
Figure 1. Enoxaparin Sodium APIs and Preparations Picture
Figure 2. By Revenue, Global Enoxaparin Sodium APIs and Preparations Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Enoxaparin Sodium APIs and Preparations Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Enoxaparin Sodium APIs and Preparations Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Enoxaparin Sodium APIs and Preparations Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Enoxaparin Sodium APIs and Preparations Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Enoxaparin Sodium APIs and Preparations Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Enoxaparin Sodium APIs and Preparations Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Enoxaparin Sodium APIs and Preparations Share of Global Market, 2019-2030
Figure 10. Global Enoxaparin Sodium APIs and Preparations Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Enoxaparin Sodium APIs and Preparations Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Enoxaparin Sodium APIs and Preparations Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Enoxaparin Sodium APIs and Preparations Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Enoxaparin Sodium APIs and Preparations Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Enoxaparin Sodium APIs and Preparations Domestic VS Export, 2022
Figure 16. Global Enoxaparin Sodium APIs and Preparations Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Enoxaparin Sodium APIs and Preparations Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Enoxaparin Sodium APIs and Preparations Production Market Share & Forecast by Region, 2019-2030
Figure 19. Enoxaparin Sodium APIs and Preparations Industry Chain
Figure 20. Enoxaparin Sodium APIs and Preparations Procurement Model
Figure 21. Enoxaparin Sodium APIs and Preparations Sales Model
Figure 22. Enoxaparin Sodium APIs and Preparations Sales Channels, Direct Sales and Distribution
Figure 23. 20 mg/0.2mL
Figure 24. 40 mg/0.4mL
Figure 25. 60 mg/0.6mL
Figure 26. 80 mg/0.8mL
Figure 27. 100 mg/1mL
Figure 28. 120 mg/0.8mL
Figure 29. 150 mg/1mL
Figure 30. 300mg/3mL
Figure 31. By Type, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030, US$ Million
Figure 32. By Type, Global Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2019-2030
Figure 33. By Type, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 34. By Type, Global Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2019-2030
Figure 35. By Type, Global Enoxaparin Sodium APIs and Preparations Price, 2019-2030, (US$/Unit)
Figure 36. Deep Vein Thrombosis
Figure 37. Pulmonary Embolism
Figure 38. Others
Figure 39. By Application, Global Enoxaparin Sodium APIs and Preparations Revenue, 2019-2030, US$ Million
Figure 40. By Application, Global Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2019-2030
Figure 41. By Application, Global Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 42. By Application, Global Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2019-2030
Figure 43. By Application, Global Enoxaparin Sodium APIs and Preparations Price, 2019-2030, (US$/Unit)
Figure 44. By Region, Global Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2019-2030
Figure 45. By Region, Global Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2019-2030
Figure 46. North America Enoxaparin Sodium APIs and Preparations Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, North America Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2022
Figure 48. Europe Enoxaparin Sodium APIs and Preparations Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country, Europe Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2022
Figure 50. Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. By Country/Region, Asia Pacific Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2022
Figure 52. South America Enoxaparin Sodium APIs and Preparations Revenue & Forecasts, 2019-2030, US$ Million
Figure 53. By Country, South America Enoxaparin Sodium APIs and Preparations Revenue Market Share, 2022
Figure 54. Middle East & Africa Enoxaparin Sodium APIs and Preparations Revenue & Forecasts, 2019-2030, US$ Million
Figure 55. U.S. Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 56. By Company, U.S. Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 57. By Type, U.S. Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, U.S. Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 59. Europe Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 60. By Company, Europe Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 61. By Type, Europe Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, Europe Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 63. China Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 64. By Company, China Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 65. By Type, China Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, China Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 67. Japan Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 68. By Company, Japan Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 69. By Type, Japan Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, Japan Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 71. South Korea Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 72. By Company, South Korea Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 73. By Type, South Korea Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, South Korea Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 75. Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 76. By Company, Southeast Asia Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 77. By Type, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, Southeast Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 79. India Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 80. By Company, India Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 81. By Type, India Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, India Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 83. Middle East & Asia Enoxaparin Sodium APIs and Preparations Sales Volume, 2019-2030, (K Units)
Figure 84. By Company, Middle East & Asia Enoxaparin Sodium APIs and Preparations Market Share, 2022
Figure 85. By Type, Middle East & Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 86. By Application, Middle East & Asia Enoxaparin Sodium APIs and Preparations Sales Volume Market Share, 2022 VS 2029
Figure 87. Research Methodology
Figure 88. Breakdown of Primary Interviews
Figure 89. Bottom-up Approaches
Figure 90. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|